跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 910 条关于
“Zr-89 girentuximab”
全部
910
临床试验
305
药物
126
机构
97
资讯
382
去年
Zr-89 Girentuximab PET-CT Shows Promise in Detecting Clear Cell Renal Cell Carcinoma
去年
Monopar Therapeutics Launches FDA-Authorized Expanded Access Program for uPAR-Targeted Radiopharmaceuticals in Advanced Cancers
去年
Dual-Targeting Radiopharmaceutical Shows 89% Response Rate in Advanced Cancer Trial
2年前
Advances and Challenges in Renal Cell Carcinoma Treatment
9个月前
Adaptive Biotechnologies' clonoSEQ MRD Test Featured in Record 89 Abstracts at ASH 2025
去年
Jasper Therapeutics' Briquilimab Shows 89% Complete Response Rate in CSU Despite Manufacturing Setbacks
去年
Shionogi's Oral Antiviral S-337395 Shows Promise in Phase 2 RSV Human Challenge Trial
去年
Agomab Therapeutics Secures $89 Million to Advance Fibrotic Disease Treatments
5个月前
Pinnacle Medicines Raises $89 Million Series B to Advance Oral Peptide Therapeutics into Clinical Trials
2个月前
Oral Shigella Vaccine Candidate WRSs2 Demonstrates 89% Efficacy in Phase 2 Controlled Human Infection Trial
第 1 页,共 39 页
上一页
下一页